Literature DB >> 19330114

Mechanistic basis for nonlinear dose-response relationships for low-dose radiation-induced stochastic effects.

Bobby R Scott1, Dale M Walker, Yohannes Tesfaigzi, Helmut Schöllnberger, Vernon Walker.   

Abstract

The linear nonthreshold (LNT) model plays a central role in low-dose radiation risk assessment for humans. With the LNT model, any radiation exposure is assumed to increase one's risk of cancer. Based on the LNT model, others have predicted tens of thousands of deaths related to environmental exposure to radioactive material from nuclear accidents (e.g., Chernobyl) and fallout from nuclear weapons testing. Here, we introduce a mechanism-based model for low-dose, radiation-induced, stochastic effects (genomic instability, apoptosis, mutations, neoplastic transformation) that leads to a LNT relationship between the risk for neoplastic transformation and dose only in special cases. It is shown that nonlinear dose-response relationships for risk of stochastic effects (problematic nonlethal mutations, neoplastic transformation) should be expected based on known biological mechanisms. Further, for low-dose, low-dose rate, low-LET radiation, large thresholds may exist for cancer induction. We summarize previously published data demonstrating large thresholds for cancer induction. We also provide evidence for low-dose-radiation-induced, protection (assumed via apoptosis) from neoplastic transformation. We speculate based on work of others (Chung 2002) that such protection may also be induced to operate on existing cancer cells and may be amplified by apoptosis-inducing agents such as dietary isothiocyanates.

Entities:  

Keywords:  low dose; model; radiation; risk

Year:  2003        PMID: 19330114      PMCID: PMC2651611          DOI: 10.1080/15401420390844492

Source DB:  PubMed          Journal:  Nonlinearity Biol Toxicol Med        ISSN: 1540-1421


  72 in total

1.  On the complexity of the DNA damage created by endogenous processes.

Authors:  R D Stewart
Journal:  Radiat Res       Date:  1999-07       Impact factor: 2.841

2.  The bystander effect in radiation oncogenesis: II. A quantitative model.

Authors:  D J Brenner; J B Little; R K Sachs
Journal:  Radiat Res       Date:  2001-03       Impact factor: 2.841

3.  Controlling the efficiency of excision repair.

Authors:  P C Hanawalt
Journal:  Mutat Res       Date:  2001-02-25       Impact factor: 2.433

4.  Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise.

Authors:  Z B Tokarskaya; B R Scott; G V Zhuntova; N D Okladnikova; Z D Belyaeva; V F Khokhryakov; H Schöllnberger; E K Vasilenko
Journal:  Health Phys       Date:  2002-12       Impact factor: 1.316

Review 5.  Spontaneous DNA damage and its significance for the "negligible dose" controversy in radiation protection.

Authors:  D Billen
Journal:  Radiat Res       Date:  1990-11       Impact factor: 2.841

6.  A generalized state-vector model for radiation-induced cellular transformation.

Authors:  D J Crawford-Brown; W Hofmann
Journal:  Int J Radiat Biol       Date:  1990-02       Impact factor: 2.694

Review 7.  Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis.

Authors:  G Bauer
Journal:  Histol Histopathol       Date:  1996-01       Impact factor: 2.303

8.  Zero tumor incidence in mice after repeated lifetime exposures to 0.5 Gy of beta radiation.

Authors:  A Ootsuyama; H Tanooka
Journal:  Radiat Res       Date:  1993-05       Impact factor: 2.841

9.  Fission-spectrum neutrons at a low dose rate enhance neoplastic transformation in the linear, low dose region (0-10 cGy).

Authors:  C K Hill; A Han; M M Elkind
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1984-07

Review 10.  Radiation-induced genomic instability in haemopoietic cells.

Authors:  E G Wright
Journal:  Int J Radiat Biol       Date:  1998-12       Impact factor: 2.694

View more
  17 in total

1.  Suppression of neoplastic transformation in vitro by low doses of low LET radiation.

Authors:  J Leslie Redpath
Journal:  Dose Response       Date:  2006-11-27       Impact factor: 2.658

2.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

3.  Stochastic thresholds: a novel explanation of nonlinear dose-response relationships for stochastic radiobiological effects.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2006-05-22       Impact factor: 2.658

4.  Nonlinear response for neoplastic transformation following low doses of low let radiation.

Authors:  J Leslie Redpath
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005-01

5.  Non-linear adaptive phenomena which decrease the risk of infection after pre-exposure to radiofrequency radiation.

Authors:  S M J Mortazavi; M Motamedifar; G Namdari; M Taheri; A R Mortazavi; N Shokrpour
Journal:  Dose Response       Date:  2013-07-18       Impact factor: 2.658

6.  Low-dose-radiation stimulated natural chemical and biological protection against lung cancer.

Authors:  B R Scott
Journal:  Dose Response       Date:  2008-03-20       Impact factor: 2.658

7.  Detrimental and protective bystander effects: a model approach.

Authors:  H Schöllnberger; R E J Mitchel; J L Redpath; D J Crawford-Brown; W Hofmann
Journal:  Radiat Res       Date:  2007-11       Impact factor: 2.841

8.  Low-dose radiation-induced protective process and implications for risk assessment, cancer prevention, and cancer therapy.

Authors:  B R Scott
Journal:  Dose Response       Date:  2007-06-04       Impact factor: 2.658

9.  Radiation-induced neoplastic transformation in vitro, hormesis and risk assessment.

Authors:  J Leslie Redpath; Eugene Elmore
Journal:  Dose Response       Date:  2006-12-06       Impact factor: 2.658

10.  Low-LET-induced radioprotective mechanisms within a stochastic two-stage cancer model.

Authors:  H Schöllnberger; R D Stewart; R E J Mitchel
Journal:  Dose Response       Date:  2006-05-22       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.